- Global Pharma News & Resources

Corp Comms

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced its sponsorship of the 2019 Simon’s Heart “Protect This Heart” student fall screening program. 

Simon’s Heart is a Philadelphia-based non-profit organization dedicated to raising awareness about the warning signs and conditions that lead to sudden cardiac arrest and death in children. ERT is the title sponsor of the organization’s upcoming youth screenings, in which thousands of children and adolescents are screened for heart abnormalities. The screenings will be held on September 21 at Germantown Academy in Fort Washington, PA and on October 19 at William Tennent High School in Warminster, PA. Information and registration for both events can be found here.  

“We’re extremely grateful to ERT for their sponsorship and for our long-standing relationship with their scientists and analysts who’ve contributed so much to our cause over the years,” said Darren Sudman, CEO and Co-founder, Simon’s Heart. “We continue to rely on ERT’s expertise in assessing cardiac safety risk and with their additional support, we’re able to provide these screenings free of charge which helps to ensure children’s safety.”

In addition to sponsoring the fall youth screenings, ERT has donated the ECG machines used at every Protect This Heart screening since 2014. ERT scientists and expert over-read analysts donate countless time every year analyzing ECG readings and uploading the vast data collected for the advancement of life-saving research across the United States.

“It’s an honor to be associated with Simon’s Heart and to support the great work they’re doing in preventing sudden cardiac arrest in children and adolescents,” said James Corrigan, President and CEO, ERT. “We’re proud that Simon’s Heart turned to ERT for our expertise in collecting and analyzing ECG data to identify pediatric heart abnormalities and look forward to continuing our relationship with them to ensure the safety of our children.”

Visit for additional information and learn more about ERT’s cardiac safety solutions at


About ERT
ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that its customers can move ahead with confidence. With nearly 50 years of clinical and therapeutic experience, ERT balances knowledge of what works with a vision for what’s next, so it can adapt without compromising standards.

Powered by the company’s EXPERT® technology platform, ERT’s solutions enhance trial oversight, enable site optimization, increase patient engagement and measure the efficacy of new clinical treatments while ensuring patient safety. Since 2013, more than half of all FDA drug approvals came from ERT-supported studies. Pharma companies, biotechs and CROs have relied on ERT solutions across 15,000 studies, spanning more than four million patients to date. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly ─ and with confidence.


For more information, go to or follow us on LinkedIn and Twitter.


About Simon’s Heart

Simon’s Heart, formerly known as Simon’s Fund, is a 501 (c)(3) organization dedicated to raising

awareness about the warning signs and conditions that lead to sudden cardiac arrest and death in

children. Darren and Phyllis Sudman founded Simon’s Fund in 2005 in memory of their three-month oldson, Simon.  He died suddenly while taking a nap from an undetected heart condition. 

Simon’s Heart has provided free heart screenings to 17,929 students. Of those tested, 137 discovered heart conditions.  It was behind the passage of the Sudden Cardiac Arrest Prevention Act in Pennsylvania, the first law in the country to protect student athletes from sudden cardiac arrest. This law has been passed in eleven other states as well. It created HeartBytes, the first-of-its-kind digital cardiac registry of seemingly healthy kids. The data and images are made available to qualified researchers, free of charge. It operates, a crowd-funding site dedicated to getting AED devices into places where kids learn and play, and has distributed 90+ AEDs. It has partnered on awareness campaigns with most of the NCAA and professional sporting teams in Philadelphia.

In 2014, Phyllis Sudman was named the 2014 Woman of Worth National Honoree by L’Oréal Paris, beating out more than 4,300 other women. Darren Sudman received the 2017 Be Well Philly Health Hero Award from Philadelphia Magazine and Independence Blue Cross. For more information please visit

Editor Details

Related Links

Last Updated: 17-Sep-2019